Literature DB >> 6180363

Evaluation of (D-Pro2, D-Trp7,9)-substance P as an antagonist of substance P responses in the rat central nervous system.

T E Salt, G J De Vries, R E Rodriguez, P M Cahusac, R Morris, R G Hill.   

Abstract

The (D-Pro2, D-Trp7,9) analogue of substance P has been tested for substance P antagonist activity in the caudal trigeminal nucleus in vivo, and in the isolated spinal cord in vitro. In neither case was the analogue found to be a specific antagonist of substance P, although the analogue did have weak antagonist actions in the isolated guinea-pig ileum preparation. It is concluded that the analogue is not a suitable tool for the identification of putative substance P systems in the spinal cord or the caudal trigeminal nucleus of the rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180363     DOI: 10.1016/0304-3940(82)90415-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus.

Authors:  J J Dreifuss; M Raggenbass
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

2.  Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat.

Authors:  Y Torrens; J C Beaujouan; A Viger; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

3.  The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.

Authors:  T Sakurada; Y Manome; K Tan-No; S Sakurada; K Kisara
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Desensitization to substance P following intrathecal injection. A technique for investigating the role of substance P in nociception.

Authors:  J Sawynok; G Robertson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.